Cargando…
Patient's weight can decide about spending millions on enzyme replacement therapy in MPS II
Autores principales: | Bik-Multanowski, Miroslaw, Jamroz, Ewa, Kaluzny, Lukasz, Pronicka, Ewa, Rokicki, Dariusz, Starostecka, Ewa, Sykut-Cegielska, Jolanta, Walczak, Mieczyslaw |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4789339/ https://www.ncbi.nlm.nih.gov/pubmed/27014570 http://dx.doi.org/10.1016/j.ymgmr.2015.12.002 |
Ejemplares similares
-
COVID-19 Pandemic and Patients with Rare Inherited Metabolic Disorders and Rare Autoinflammatory Diseases—Organizational Challenges from the Point of View of Healthcare Providers
por: Tobór-Świętek, Ewa, et al.
Publicado: (2021) -
Drug-resistant epilepsia and fulminant valproate liver toxicity. Alpers-Huttenlocher syndrome in two children confirmed post mortem by identification of p.W748S mutation in POLG gene
por: Pronicka, Ewa, et al.
Publicado: (2011) -
Cross-border healthcare? The Polish experience
por: Sykut-Cegielska, Jolanta
Publicado: (2010) -
From the Editor-in-Chief
por: Sykut-Cegielska, Jolanta
Publicado: (2020) -
Carriership of the rs113883650/rs2287120 haplotype of the SLC7A5 (LAT1) gene increases the risk of obesity in infants with phenylketonuria
por: Bik-Multanowski, Miroslaw, et al.
Publicado: (2020)